N- ( 2-thiazolyl) -amide derivatives as GSK-3 inhibitors

Details for Australian Patent Application No. 2007245625 (hide)

Owner NOSCIRA, S.A.

Inventors Alonso Cascon, Mercedes; Medina Padilla, Miguel; Del Monte Millan, Maria; Navarro Rico, Maria Luisa; Martin Aparicio, Ester; Castro Morera, Ana; Fuertes Huerta, Ana; Perez Puerto, Maria Jose; Martinez Gil, Ana

Agent Collison & Co

Pub. Number AU-B-2007245625

PCT Pub. Number WO2007/125110

Priority 60/878,386 04.01.07 US; 06380099.9 28.04.06 EP

Filing date 27 April 2007

Wipo publication date 8 November 2007

Acceptance publication date 5 July 2012

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/426 - 1,3-Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/125110 Priority application(s): WO2007/125110

5 July 2012 Application Accepted

  Published as AU-B-2007245625

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007245654-Antimicrobial linear peptides

2007245624-N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors